Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

By Avritscher Elenir  

Supportive Care in Cancer, Vol. 12, Iss. 7, 2004-07 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite

On the Origins of the Androgen Receptor Low Molecular Weight Species

By Mudryj Maria   Tepper Clifford  

Hormones and Cancer, Vol. 4, Iss. 5, 2013-10 ,pp. : 259-269

Springer Publishing Company

Access to resources Recommend Favorite

Low Molecular Weight Heparins as Antineoplastic Agents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 159-161

Bentham Science Publishers

Access to resources Recommend Favorite

Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-367

Spandidos Publications

Access to resources Recommend Favorite

The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery

By Jeong Oh  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2363-2369

Springer Publishing Company

Access to resources Recommend Favorite